Nov 15, 2022 / 08:00AM GMT
Peter Welford - Jefferies & Co. - Analyst
Good morning. I think this is the first presentation in this track, so, I welcome you all to the Jefferies 2022 Healthcare Conference in London. Because you don't know me, my name is Peter Welford, I have AC Immune, today, the CEO, Andrea Pfeifer.
Andrea's going to walk through a few slides, and give you a background as an intro to the company, and then, we'll go to Q&A. As usual, if anyone in the audience has any questions, please raise your hand. We have dozen who would love some participation, of now -- I'll just continue in the usual vein.
And with that, over to Andrea, and thank you very much.
Andrea Pfeifer - AC Immune SA - CEO, Co-Founder, Director
Good morning. Thank you for joining. I'm happy to speak to you about AC Immune company, pioneering precision medicine in neurodegenerative diseases.
Today, I will give at the beginning, just a short overview of our company, followed by an update on the pipeline, and our upcoming milestones. So -- What you will see later, AC Immune
AC Immune SA at Jefferies London Healthcare Conference Transcript
Nov 15, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers